omeprazole has been researched along with Diabetes Mellitus, Type 1 in 7 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty nine patients with type 1 diabetes mellitus and H." | 2.69 | Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. ( Aller, R; Boixeda de Miquel, D; de la Calle, H; de Luis, DA; Garcia Avello, A; Lasuncion, MA; Martin de Argila, C, 1999) |
| " pylori eradication rate with a standard triple therapy regardless of the regimen utilized, the dosage and/or the duration of the therapy used appearing not to be sufficient to eradicate the infection efficiently." | 2.69 | Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. ( Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG, 2000) |
| "A diagnosis of toxic epidermal necrolysis (TEN) was made." | 2.45 | Toxic epidermal necrolysis and neutropaenia: complications of omeprazole. ( Burke, A; Burns, A; Handfield-Jones, S; Palmer, M; Sinha, A; Thakor, AS, 2009) |
| "The study included 100 youth with type 1 diabetes and seropositive for Hp (European Caucasians: n=49; Moghrabin Caucasians: n=51)." | 1.34 | [Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes]. ( Dorchy, H; Khalil, T; Melot, C; Scaillon, M, 2007) |
| "pylori in children with type 1 diabetes mellitus improves their metabolic control." | 1.32 | Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. ( Cammarota, G; Candelli, M; Crea, F; Gasbarrini, A; Gasbarrini, G; Marietti, G; Nista, EC; Petrucci, S; Pignataro, G; Rigante, D; Schiavino, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lagunas-Rangel, FA | 1 |
| Koshelev, D | 1 |
| Nedorubov, A | 1 |
| Kosheleva, L | 1 |
| Trukhan, V | 1 |
| Rabinovitch, A | 1 |
| Schiöth, HB | 1 |
| Levit, S | 1 |
| Thakor, AS | 1 |
| Burke, A | 1 |
| Handfield-Jones, S | 1 |
| Sinha, A | 1 |
| Palmer, M | 1 |
| Burns, A | 1 |
| Candelli, M | 1 |
| Rigante, D | 1 |
| Marietti, G | 1 |
| Nista, EC | 1 |
| Crea, F | 1 |
| Schiavino, A | 1 |
| Cammarota, G | 1 |
| Pignataro, G | 1 |
| Petrucci, S | 1 |
| Gasbarrini, G | 2 |
| Gasbarrini, A | 2 |
| Khalil, T | 1 |
| Dorchy, H | 1 |
| Scaillon, M | 1 |
| Melot, C | 1 |
| de Luis, DA | 2 |
| Garcia Avello, A | 1 |
| Lasuncion, MA | 1 |
| Aller, R | 2 |
| Martin de Argila, C | 1 |
| Boixeda de Miquel, D | 1 |
| de la Calle, H | 2 |
| Ojetti, V | 1 |
| Pitocco, D | 1 |
| Armuzzi, A | 1 |
| Silveri, NG | 1 |
| Pola, P | 1 |
| Ghirlanda, G | 1 |
| Cordero, JM | 1 |
| Caballero, C | 1 |
| Boixeda, D | 1 |
| Cantón, R | 1 |
1 review available for omeprazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Toxic epidermal necrolysis and neutropaenia: complications of omeprazole.
Topics: Acute Kidney Injury; Adult; Biopsy, Needle; Combined Modality Therapy; Diabetes Mellitus, Type 1; Di | 2009 |
2 trials available for omeprazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.
Topics: Adult; Amoxicillin; Analysis of Variance; Body Mass Index; Breath Tests; Cholesterol; Clarithromycin | 1999 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bism | 2000 |
4 other studies available for omeprazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice.
Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase | 2022 |
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Benz | 2004 |
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].
Topics: Adolescent; Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulce | 2007 |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, T | 2001 |